Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.
Share:
More In Business
FDA Warns of Fake Ozempic Drugs
The Food and Drug Administration warned consumers about a copycat version of the diabetes drug Ozempic.
Report: Tesla Building Battery Factory in China
Tesla is reportedly moving forward with its plan to make energy shortage storage batteries in China.
Wells Fargo Workers in New Mexico Vote to Unionize
Wells Fargo employees at a branch in New Mexico have voted to unionize.
Nike Cuts Full-Year Revenue Outlook and Announces Cost-Cutting Plan
Nike cut its full-year revenue outlook for the fiscal year after reporting lower-than-expected revenue in its latest quarter.
Stocks Rise As Market Looks to Extend Winning Streak Year-End
Stocks climbed after the opening bell as the market looks to extend its winning streak as the year draws to a close.
Pres. Biden Says U.S. Steel Deal Needs 'Serious Scrutiny'
President Biden thinks there should be "serious" scrutiny over Japanese company Nippon's planned purchase of US Steel.
Were Your Holiday Deliveries Stolen? What to Know About Porch Piracy and What You Can Do About It
You found the perfect holiday gift online. You ordered it. A notification arrived on your phone, showing the package had arrived. But when you open your doors, the parcel is nowhere to be found.
Airbnb Fined at Least $10M for Misleading Australian Customers
Airbnb has admitted to misleading its customers in Australia by not making clear that prices on its site were listed in U.S. dollars instead of Australian dollars.
American Consumers Are More Confident
Business research group The Conference Board said that its consumer confidence index increased two months in a row.
